Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases

Qi Wu,Jiangting Yao,Mengyun Xiao,Xiawei Zhang,Mengxiao Zhang,Xinting Xi
DOI: https://doi.org/10.1080/1061186x.2024.2356736
2024-05-25
Journal of Drug Targeting
Abstract:Cardiovascular diseases (CVDs) are the leading cause of death globally, with oxidative stress (OS) identified as a primary contributor to their onset and progression. Given the elevated incidence and mortality rates associated with CVDs, there is an imperative need to investigate novel therapeutic strategies. Nuclear factor erythroid 2-related factor 2 (Nrf2), ubiquitously expressed in the cardiovascular system, has emerged as a promising therapeutic target for CVDs due to its role in regulating OS and inflammation. This review aims to delve into the mechanisms and actions of the Nrf2 pathway, highlighting its potential in mitigating the pathogenesis of CVDs.
pharmacology & pharmacy
What problem does this paper attempt to address?